Genius Sports Limited (NYSE:GENI) Q2 2021 Earnings Conference Call September 8, 2021 8:00 AM ET
Company Participants
Mark Locke - Co-Founder and Chief Executive Officer
Nicholas Taylor - Chief Financial Officer
Jack Davison - Chief Commercial Officer
Josh Linforth - Commercial Director, Media & Engagement
Conference Call Participants
Stephen Grambling - Goldman Sachs
Jed Kelly - Oppenheimer
Bernie McTernan - Needham & Company
Ryan Sigdahl - Craig-Hallum Capital
Robin Farley - UBS
Operator
Welcome to the Genius Sports Q2 Results Call 2021. Throughout the call, all participants will be in a listen-only mode and afterwards there will be a question-and-answer session. [Operator Instructions]
Please go ahead with your meeting.
Nicholas Taylor
Good morning, everyone and thank you for joining. Before we begin, we'd like to remind you that certain statements made during this call may constitute forward-looking statements that are subject to risks that could cause our actual results to differ materially from our historical results or from our forecasts. We assume no responsibility for updating forward-looking statements. Any such statements should be considered in conjunction with cautionary statements in our earnings release and risk factor discussions in our filings with the SEC, including our last annual report on Form 20-F filed on April 30.
During the call, management will also discuss certain non-GAAP measures that we believe may be useful in evaluating Genius's operating performance. These measures should not be considered in isolation or as a substitute for Genius's financial results prepared in accordance with U.S. GAAP. A reconciliation of these non-GAAP measures to the most directly comparable U.S GAAP measures is available in our earnings press release and earnings presentation, which can be found on our website at investor.geniussports.com.
With that, I'll now turn the call over to Mark Locke.
Mark Locke
Good morning and thank you for
- Read more current GENI analysis and news
- View all earnings call transcripts